LISINOGLEN 20 price in UAE

Overview

Welcome to Dwaey, specifically on LISINOGLEN 20 Tablets page.
This medicine contains an important and useful components, as it consists of Lisinopril (as dihydrate).
LISINOGLEN 20 is available in the market in concentration 20mg/Tablet and in the form of Tablets.

GLENMARK PHARMACEUTICALS is the producer of LISINOGLEN 20 and it is imported from UAE, The most popular alternatives of LISINOGLEN 20 are listed downward .

Mode Of Action

Lisinopril competitively inhibits ACE from converting angiotensin I to angiotensin II (a potent vasoconstrictor) resulting in increased plasma renin activity and reduced aldosterone (a hormone that causes water and Na retention) secretion. This promotes vasodilation and BP reduction.

Indication

Heart failure
Myocardial infarction
Diabetic nephropathy
Hypertension

Precaution

Hypovolaemia, hyperkalaemia, collagen vascular disease, valvular stenosis; before, during or immediately after anaesthesia, preexisting renal insufficiency, unilateral renal artery stenosis. Children <6 yr. Assess renal function. May impair ability to drive or operate machinery. Lactation: Not known if excreted into breast milk; not recommended

Side Effects

>10% Dizziness (5-12%) 1-10% Cough (4-9%)
Headache (4-6%)
Hyperkalemia (2-5%)
Diarrhea (3-4%)
Hypotension (1-4%)
Chest pain (3%)
Fatigue (3%)
Nausea/vomiting (2%)
Kidney disease
of AMI patients (2%)
Rash (1-2%) <1% Immune hypersensitivity reaction
Psoriasis
Angioedema of the face
lips
throat; intestinal angioedema
Anuria
Atrial tachycardia
Acute renal failure
Arthralgia
Alopecia
Atrial fibrillation
Bone marrow suppression
Cutaneous pseudolymphoma
Hypersomnia
Leukopenia
Mood changes
Pancreatitis
Skin infections Potentially Fatal: Severe hypotension
angioedema.

Contra indication

History of angioedema related to previous treatment with ACE inhibitors, hereditary or idiopathic angioedema. Bilateral renal artery stenosis. Pregnancy (2nd or 3rd trimester), lactation.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Interaction

May enhance hypotensive effect w/ diuretics. May increase risk of renal function deterioration and decrease antihypertensive effect w/ NSAIDs. May increase serum levels and toxicity of lithium. Increased risk of hyperkalaemia w/ K-sparing diuretics and K supplements. May increase nitritoid reactions of gold Na thiomalate. Potentially Fatal: Increased risk of hypotension, hyperkalaemia and changes in renal function w/ aliskiren in patients w/ diabetes or renal impairment.